HEADER TRANSFERASE 22-SEP-08 3ELJ TITLE JNK1 COMPLEXED WITH A BIS-ANILINO-PYRROLOPYRIMIDINE INHIBITOR. COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 8; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: STRESS-ACTIVATED PROTEIN KINASE JNK1, C-JUN N-TERMINAL COMPND 5 KINASE 1, JNK-46; COMPND 6 EC: 2.7.11.24; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK8, JNK1, PRKM8; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX 6P1 KEYWDS C-JUN N-TERMINAL KINASE, MITOGEN-ACTIVATED PROTEIN KINASE, ATP- KEYWDS 2 BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, KEYWDS 3 SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, JNK1 EXPDTA X-RAY DIFFRACTION AUTHOR S.CHAMBERLAIN,C.ATKINS,F.DEANDA,M.DUMBLE,R.GERDING,A.GROY, AUTHOR 2 S.KORENCHUK,R.KUMAR,H.LEI,R.MOOK,G.MOORTHY,A.REDMAN,J.ROWLAND, AUTHOR 3 L.SHEWCHUK,G.VICENTINI,J.MOSLEY REVDAT 4 06-SEP-23 3ELJ 1 REMARK SEQADV REVDAT 3 13-JUL-11 3ELJ 1 VERSN REVDAT 2 06-JAN-09 3ELJ 1 JRNL REVDAT 1 30-DEC-08 3ELJ 0 JRNL AUTH S.D.CHAMBERLAIN,A.M.REDMAN,J.W.WILSON,F.DEANDA,J.B.SHOTWELL, JRNL AUTH 2 R.GERDING,H.LEI,B.YANG,K.L.STEVENS,A.M.HASSELL,L.M.SHEWCHUK, JRNL AUTH 3 M.A.LEESNITZER,J.L.SMITH,P.SABBATINI,C.ATKINS,A.GROY, JRNL AUTH 4 J.L.ROWAND,R.KUMAR,R.A.MOOK,G.MOORTHY,S.PATNAIK JRNL TITL OPTIMIZATION OF 4,6-BIS-ANILINO-1H-PYRROLO[2,3-D]PYRIMIDINE JRNL TITL 2 IGF-1R TYROSINE KINASE INHIBITORS TOWARDS JNK SELECTIVITY. JRNL REF BIOORG.MED.CHEM.LETT. V. 19 360 2009 JRNL REFN ISSN 0960-894X JRNL PMID 19071018 JRNL DOI 10.1016/J.BMCL.2008.11.077 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 35293 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1871 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2545 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.53 REMARK 3 BIN R VALUE (WORKING SET) : 0.2150 REMARK 3 BIN FREE R VALUE SET COUNT : 133 REMARK 3 BIN FREE R VALUE : 0.2480 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2783 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 325 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.95 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.97000 REMARK 3 B22 (A**2) : -0.55000 REMARK 3 B33 (A**2) : -0.42000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.133 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.121 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.077 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.650 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3071 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4196 ; 1.041 ; 1.984 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 383 ; 5.053 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 137 ;34.898 ;24.307 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 537 ;12.199 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;15.174 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 452 ; 0.067 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2461 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1446 ; 0.188 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2180 ; 0.299 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 279 ; 0.118 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 52 ; 0.105 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 22 ; 0.109 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1927 ; 0.573 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3039 ; 0.807 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1343 ; 1.251 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1157 ; 1.957 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 112 REMARK 3 ORIGIN FOR THE GROUP (A): 18.7320 13.9920 41.8980 REMARK 3 T TENSOR REMARK 3 T11: -0.0296 T22: -0.0506 REMARK 3 T33: -0.0649 T12: -0.0128 REMARK 3 T13: 0.0019 T23: 0.0092 REMARK 3 L TENSOR REMARK 3 L11: 1.3060 L22: 1.4382 REMARK 3 L33: 1.8652 L12: -0.2573 REMARK 3 L13: 0.4106 L23: -0.4525 REMARK 3 S TENSOR REMARK 3 S11: -0.0580 S12: 0.0060 S13: 0.0998 REMARK 3 S21: 0.1640 S22: -0.0567 S23: -0.0691 REMARK 3 S31: -0.0268 S32: 0.0509 S33: 0.1147 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 113 A 365 REMARK 3 ORIGIN FOR THE GROUP (A): 15.3640 15.7380 15.6750 REMARK 3 T TENSOR REMARK 3 T11: -0.0603 T22: -0.0590 REMARK 3 T33: -0.0413 T12: 0.0009 REMARK 3 T13: -0.0066 T23: -0.0008 REMARK 3 L TENSOR REMARK 3 L11: 0.5007 L22: 0.5875 REMARK 3 L33: 1.3841 L12: 0.0837 REMARK 3 L13: 0.2312 L23: 0.1705 REMARK 3 S TENSOR REMARK 3 S11: -0.0076 S12: 0.0060 S13: 0.0551 REMARK 3 S21: 0.0459 S22: 0.0467 S23: -0.0425 REMARK 3 S31: -0.0554 S32: 0.0097 S33: -0.0391 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3ELJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-SEP-08. REMARK 100 THE DEPOSITION ID IS D_1000049473. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-NOV-06 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35293 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 59.760 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.19100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2Q01 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG3350, 0.1M SODIUM HEPES, 15% REMARK 280 GYLCEROL ADDED AS A CRYOPROTECTANT PRIOR TO FREEZING., PH 7.5, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.37250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.34600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.73250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.34600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.37250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.73250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -4 REMARK 465 PRO A -3 REMARK 465 LEU A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ARG A 3 REMARK 465 SER A 4 REMARK 465 LYS A 5 REMARK 465 ARG A 6 REMARK 465 ALA A 173 REMARK 465 ARG A 174 REMARK 465 THR A 175 REMARK 465 ALA A 176 REMARK 465 GLY A 177 REMARK 465 THR A 178 REMARK 465 ASP A 339 REMARK 465 LYS A 340 REMARK 465 GLN A 341 REMARK 465 LEU A 342 REMARK 465 ASP A 343 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 7 CG OD1 OD2 REMARK 470 ASP A 17 CG OD1 OD2 REMARK 470 LYS A 30 CD CE NZ REMARK 470 LYS A 68 CE NZ REMARK 470 LYS A 96 CD CE NZ REMARK 470 SER A 179 OG REMARK 470 LYS A 222 CE NZ REMARK 470 LYS A 250 CG CD CE NZ REMARK 470 LYS A 273 CE NZ REMARK 470 LYS A 336 CG CD CE NZ REMARK 470 GLU A 344 CG CD OE1 OE2 REMARK 470 GLU A 346 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 102 -62.49 -125.70 REMARK 500 GLN A 102 -56.36 -129.95 REMARK 500 ARG A 150 -14.77 76.44 REMARK 500 CYS A 163 5.18 80.04 REMARK 500 ALA A 282 27.19 -155.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GS7 A 365 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3EKK RELATED DB: PDB REMARK 900 RELATED ID: 3EKN RELATED DB: PDB DBREF 3ELJ A 1 364 UNP P45983 MK08_HUMAN 1 364 SEQADV 3ELJ GLY A -4 UNP P45983 EXPRESSION TAG SEQADV 3ELJ PRO A -3 UNP P45983 EXPRESSION TAG SEQADV 3ELJ LEU A -2 UNP P45983 EXPRESSION TAG SEQADV 3ELJ GLY A -1 UNP P45983 EXPRESSION TAG SEQADV 3ELJ SER A 0 UNP P45983 EXPRESSION TAG SEQRES 1 A 369 GLY PRO LEU GLY SER MET SER ARG SER LYS ARG ASP ASN SEQRES 2 A 369 ASN PHE TYR SER VAL GLU ILE GLY ASP SER THR PHE THR SEQRES 3 A 369 VAL LEU LYS ARG TYR GLN ASN LEU LYS PRO ILE GLY SER SEQRES 4 A 369 GLY ALA GLN GLY ILE VAL CYS ALA ALA TYR ASP ALA ILE SEQRES 5 A 369 LEU GLU ARG ASN VAL ALA ILE LYS LYS LEU SER ARG PRO SEQRES 6 A 369 PHE GLN ASN GLN THR HIS ALA LYS ARG ALA TYR ARG GLU SEQRES 7 A 369 LEU VAL LEU MET LYS CYS VAL ASN HIS LYS ASN ILE ILE SEQRES 8 A 369 GLY LEU LEU ASN VAL PHE THR PRO GLN LYS SER LEU GLU SEQRES 9 A 369 GLU PHE GLN ASP VAL TYR ILE VAL MET GLU LEU MET ASP SEQRES 10 A 369 ALA ASN LEU CYS GLN VAL ILE GLN MET GLU LEU ASP HIS SEQRES 11 A 369 GLU ARG MET SER TYR LEU LEU TYR GLN MET LEU CYS GLY SEQRES 12 A 369 ILE LYS HIS LEU HIS SER ALA GLY ILE ILE HIS ARG ASP SEQRES 13 A 369 LEU LYS PRO SER ASN ILE VAL VAL LYS SER ASP CYS THR SEQRES 14 A 369 LEU LYS ILE LEU ASP PHE GLY LEU ALA ARG THR ALA GLY SEQRES 15 A 369 THR SER PHE MET MET THR PRO TYR VAL VAL THR ARG TYR SEQRES 16 A 369 TYR ARG ALA PRO GLU VAL ILE LEU GLY MET GLY TYR LYS SEQRES 17 A 369 GLU ASN VAL ASP LEU TRP SER VAL GLY CYS ILE MET GLY SEQRES 18 A 369 GLU MET VAL CYS HIS LYS ILE LEU PHE PRO GLY ARG ASP SEQRES 19 A 369 TYR ILE ASP GLN TRP ASN LYS VAL ILE GLU GLN LEU GLY SEQRES 20 A 369 THR PRO CYS PRO GLU PHE MET LYS LYS LEU GLN PRO THR SEQRES 21 A 369 VAL ARG THR TYR VAL GLU ASN ARG PRO LYS TYR ALA GLY SEQRES 22 A 369 TYR SER PHE GLU LYS LEU PHE PRO ASP VAL LEU PHE PRO SEQRES 23 A 369 ALA ASP SER GLU HIS ASN LYS LEU LYS ALA SER GLN ALA SEQRES 24 A 369 ARG ASP LEU LEU SER LYS MET LEU VAL ILE ASP ALA SER SEQRES 25 A 369 LYS ARG ILE SER VAL ASP GLU ALA LEU GLN HIS PRO TYR SEQRES 26 A 369 ILE ASN VAL TRP TYR ASP PRO SER GLU ALA GLU ALA PRO SEQRES 27 A 369 PRO PRO LYS ILE PRO ASP LYS GLN LEU ASP GLU ARG GLU SEQRES 28 A 369 HIS THR ILE GLU GLU TRP LYS GLU LEU ILE TYR LYS GLU SEQRES 29 A 369 VAL MET ASP LEU GLU HET GS7 A 365 45 HETNAM GS7 2-FLUORO-6-{[2-({2-METHOXY-4-[(METHYLSULFONYL) HETNAM 2 GS7 METHYL]PHENYL}AMINO)-7H-PYRROLO[2,3-D]PYRIMIDIN-4- HETNAM 3 GS7 YL]AMINO}BENZAMIDE FORMUL 2 GS7 C22 H21 F N6 O4 S FORMUL 3 HOH *325(H2 O) HELIX 1 1 PRO A 60 GLN A 62 5 3 HELIX 2 2 ASN A 63 VAL A 80 1 18 HELIX 3 3 LEU A 115 GLN A 120 1 6 HELIX 4 4 ASP A 124 ALA A 145 1 22 HELIX 5 5 LYS A 153 SER A 155 5 3 HELIX 6 6 ALA A 193 LEU A 198 1 6 HELIX 7 7 ASN A 205 HIS A 221 1 17 HELIX 8 8 ASP A 229 GLY A 242 1 14 HELIX 9 9 CYS A 245 LYS A 250 1 6 HELIX 10 10 GLN A 253 ARG A 263 1 11 HELIX 11 11 SER A 270 PHE A 275 1 6 HELIX 12 12 PRO A 276 PHE A 280 5 5 HELIX 13 13 SER A 284 LEU A 302 1 19 HELIX 14 14 SER A 311 HIS A 318 1 8 HELIX 15 15 ILE A 321 TYR A 325 5 5 HELIX 16 16 ASP A 326 GLU A 331 1 6 HELIX 17 17 THR A 348 ASP A 362 1 15 SHEET 1 A 2 PHE A 10 ILE A 15 0 SHEET 2 A 2 SER A 18 LEU A 23 -1 O SER A 18 N ILE A 15 SHEET 1 B 5 TYR A 26 GLY A 35 0 SHEET 2 B 5 GLY A 38 ASP A 45 -1 O ALA A 42 N LYS A 30 SHEET 3 B 5 ARG A 50 SER A 58 -1 O VAL A 52 N ALA A 43 SHEET 4 B 5 ASP A 103 GLU A 109 -1 O VAL A 104 N LEU A 57 SHEET 5 B 5 ASN A 90 PHE A 92 -1 N ASN A 90 O VAL A 107 SHEET 1 C 3 ALA A 113 ASN A 114 0 SHEET 2 C 3 ILE A 157 VAL A 159 -1 O VAL A 159 N ALA A 113 SHEET 3 C 3 LEU A 165 ILE A 167 -1 O LYS A 166 N VAL A 158 SITE 1 AC1 18 ILE A 32 GLY A 33 SER A 34 GLY A 35 SITE 2 AC1 18 VAL A 40 ALA A 53 GLU A 109 MET A 111 SITE 3 AC1 18 ASP A 112 ALA A 113 ASN A 114 GLN A 117 SITE 4 AC1 18 SER A 155 ASN A 156 LEU A 168 HOH A 507 SITE 5 AC1 18 HOH A 518 HOH A 605 CRYST1 50.745 71.465 108.692 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019707 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013993 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009200 0.00000